Company registration number 08359955 (England and Wales)
FORM HEALTH (UK) LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025
PAGES FOR FILING WITH REGISTRAR
FORM HEALTH (UK) LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 7
FORM HEALTH (UK) LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT 31 JANUARY 2025
31 January 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
4
9,067
15,786
Tangible assets
5
2,052
3,135
11,119
18,921
Current assets
Debtors
6
188,451
112,957
Cash at bank and in hand
147,535
47,788
335,986
160,745
Creditors: amounts falling due within one year
7
(173,544)
(105,200)
Net current assets
162,442
55,545
Total assets less current liabilities
173,561
74,466
Creditors: amounts falling due after more than one year
8
(3,334)
(13,333)
Net assets
170,227
61,133
Capital and reserves
Called up share capital
9
185
197
Capital redemption reserve
15
3
Profit and loss reserves
170,027
60,933
Total equity
170,227
61,133

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 20 October 2025 and are signed on its behalf by:
Mr J D Newman
Director
Company Registration No. 08359955
FORM HEALTH (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025
- 2 -
1
Accounting policies
Company information

Form Health (UK) Limited is a private company limited by shares incorporated in England and Wales. The registered office is 325-327 Oldfield Lane North, Greenford, Middlesex, UB6 0FX.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Software
Over 3 years
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

FORM HEALTH (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 3 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment
33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

FORM HEALTH (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 4 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

FORM HEALTH (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 5 -
1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
9
9
4
Intangible fixed assets
Goodwill
Other
Total
£
£
£
Cost
At 1 February 2024 and 31 January 2025
56,200
20,160
76,360
Amortisation and impairment
At 1 February 2024
56,200
4,374
60,574
Amortisation charged for the year
-
0
6,719
6,719
At 31 January 2025
56,200
11,093
67,293
Carrying amount
At 31 January 2025
-
0
9,067
9,067
At 31 January 2024
-
0
15,786
15,786
FORM HEALTH (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 6 -
5
Tangible fixed assets
Computer equipment
£
Cost
At 1 February 2024
14,304
Additions
1,166
Disposals
(2,655)
At 31 January 2025
12,815
Depreciation and impairment
At 1 February 2024
11,169
Depreciation charged in the year
2,249
Eliminated in respect of disposals
(2,655)
At 31 January 2025
10,763
Carrying amount
At 31 January 2025
2,052
At 31 January 2024
3,135
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
126,608
102,264
Other debtors
61,843
10,693
188,451
112,957
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
10,029
10,062
Trade creditors
76,167
61,652
Corporation tax
69,116
13,850
Other taxation and social security
7,382
7,216
Other creditors
10,850
12,420
173,544
105,200
FORM HEALTH (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 7 -
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
3,334
13,333
9
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
Ordinary B shares of £1 each
85
85
85
85
Ordinary C shares of £1 each
0
12
-
0
12
185
197
185
197

During the year the company undertook a capital reorganisation whereby the Ordinary C shares of £1 each were purchased for £12,000 from distributable reserves.

10
Directors' transactions

Dividends totalling £81,000 (2024 - £82,000) were paid in the year in respect of shares held by the company's directors.

Advances or credits have been granted by the company to its directors as follows:

Description
% Rate
Opening balance
Amounts advanced
Interest charged
Amounts repaid
Closing balance
£
£
£
£
£
Mr J Benton -
2.25
-
50,000
316
-
50,316
Mr J D Newman -
-
(1,335)
-
-
(500)
(1,835)
(1,335)
50,000
316
(500)
48,481
2025-01-31 2024-02-01 false false false 20 October 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Mr J D Newman Mrs A Newman Mr J Benton 08359955 2024-02-01 2025-01-31 08359955 2025-01-31 08359955 2024-01-31 08359955 core:NetGoodwill 2025-01-31 08359955 core:IntangibleAssetsOtherThanGoodwill 2025-01-31 08359955 core:NetGoodwill 2024-01-31 08359955 core:IntangibleAssetsOtherThanGoodwill 2024-01-31 08359955 core:ComputerEquipment 2025-01-31 08359955 core:ComputerEquipment 2024-01-31 08359955 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 08359955 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 08359955 core:Non-currentFinancialInstruments core:AfterOneYear 2025-01-31 08359955 core:Non-currentFinancialInstruments core:AfterOneYear 2024-01-31 08359955 core:CurrentFinancialInstruments 2025-01-31 08359955 core:CurrentFinancialInstruments 2024-01-31 08359955 core:ShareCapital 2025-01-31 08359955 core:ShareCapital 2024-01-31 08359955 core:CapitalRedemptionReserve 2025-01-31 08359955 core:CapitalRedemptionReserve 2024-01-31 08359955 core:RetainedEarningsAccumulatedLosses 2025-01-31 08359955 core:RetainedEarningsAccumulatedLosses 2024-01-31 08359955 core:ShareCapitalOrdinaryShareClass1 2025-01-31 08359955 core:ShareCapitalOrdinaryShareClass1 2024-01-31 08359955 core:ShareCapitalOrdinaryShareClass2 2025-01-31 08359955 core:ShareCapitalOrdinaryShareClass2 2024-01-31 08359955 core:ShareCapitalOrdinaryShareClass3 2025-01-31 08359955 core:ShareCapitalOrdinaryShareClass3 2024-01-31 08359955 core:ShareCapitalOrdinaryShares 2025-01-31 08359955 core:ShareCapitalOrdinaryShares 2024-01-31 08359955 bus:Director1 2024-02-01 2025-01-31 08359955 core:Goodwill 2024-02-01 2025-01-31 08359955 core:IntangibleAssetsOtherThanGoodwill 2024-02-01 2025-01-31 08359955 core:ComputerSoftware 2024-02-01 2025-01-31 08359955 core:ComputerEquipment 2024-02-01 2025-01-31 08359955 2023-02-01 2024-01-31 08359955 core:NetGoodwill 2024-01-31 08359955 core:IntangibleAssetsOtherThanGoodwill 2024-01-31 08359955 2024-01-31 08359955 core:NetGoodwill 2024-02-01 2025-01-31 08359955 core:ComputerEquipment 2024-01-31 08359955 core:WithinOneYear 2025-01-31 08359955 core:WithinOneYear 2024-01-31 08359955 core:Non-currentFinancialInstruments 2025-01-31 08359955 core:Non-currentFinancialInstruments 2024-01-31 08359955 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 08359955 bus:OrdinaryShareClass2 2024-02-01 2025-01-31 08359955 bus:OrdinaryShareClass3 2024-02-01 2025-01-31 08359955 bus:OrdinaryShareClass1 2025-01-31 08359955 bus:OrdinaryShareClass1 2024-01-31 08359955 bus:OrdinaryShareClass2 2025-01-31 08359955 bus:OrdinaryShareClass2 2024-01-31 08359955 bus:OrdinaryShareClass3 2025-01-31 08359955 bus:OrdinaryShareClass3 2024-01-31 08359955 bus:AllOrdinaryShares 2025-01-31 08359955 bus:AllOrdinaryShares 2024-01-31 08359955 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 08359955 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 08359955 bus:FRS102 2024-02-01 2025-01-31 08359955 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 08359955 bus:Director2 2024-02-01 2025-01-31 08359955 bus:Director3 2024-02-01 2025-01-31 08359955 bus:FullAccounts 2024-02-01 2025-01-31 xbrli:pure xbrli:shares iso4217:GBP